{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T21:40:08Z","timestamp":1772660408664,"version":"3.50.1"},"reference-count":28,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>While most cases of thrombotic microangiopathic hemolytic anemias are idiopathic, some can occur in the setting of a malignancy. Differentiating both conditions is crucial to initiate the appropriate treatment. In this case report and literature review, we discuss the occurrence of a thrombotic microangiopathy in a 61-year-old male patient with a treatment-refractory metastatic colorectal cancer invading his bone marrow. Plasmapheresis does not constitute the mainstay of treatment in this setting, as targeting the primary disease is the ultimate management. Treating the condition of our patient has been challenging as multiple lines of treatments of his primary disease had been exhausted. The discrepancy in KRAs status obtained between PCR and later NGS offered a new treatment line with Cetuximab. In this article, we will discuss the different factors that differentiate between idiopathic and cancer-induced microangiopathy. We will emphasize on the fact that the treatment of the primary disease constitutes the most important step in the treatment of cancer-induced thrombotic microangiopathy. We will also raise several explanations to target the disagreement in KRAS status obtained by the different technical modalities.<\/jats:p>","DOI":"10.3390\/hematolrep15010002","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T05:02:30Z","timestamp":1672808550000},"page":"9-16","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thrombotic Microangiopathy in the Setting of Colorectal Cancer: A Therapeutic Challenge with a Bad Prognosis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1704-3712","authenticated-orcid":false,"given":"Youssef","family":"Bouferraa","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolla","family":"Haibe","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Hamdan","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Mahfouz","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaher","family":"Chakhachiro","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3725-8403","authenticated-orcid":false,"given":"Ali","family":"Shamseddine","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology-Oncology, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Thrombotic thrombocytopenic purpura","volume":"3","author":"Hovinga","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura\u2013hemolytic uremic syndrome: Clinical experience in 108 patients","volume":"325","author":"Bell","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1200\/JOP.2016.012096","article-title":"Microangiopathic hemolytic anemia and thrombocytopenia in patients with cancer","volume":"12","author":"Morton","year":"2016","journal-title":"J. Oncol. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/ndt\/gfl565","article-title":"Thrombotic microangiopathy and anti-VEGF agents","volume":"22","author":"Izzedine","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MD.0b013e3182603598","article-title":"Cancer-related microangiopathic hemolytic anemia: Clinical and laboratory features in 168 reported cases","volume":"91","author":"Lechner","year":"2012","journal-title":"Medicine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/jjco\/hyh082","article-title":"A case of bone marrow necrosis with thrombotic thrombocytopenic purpura as a manifestation of occult colon cancer","volume":"34","author":"Lee","year":"2004","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4065\/77.8.873","article-title":"Carcinoma of the colon in a patient presenting with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"77","author":"Daily","year":"2002","journal-title":"Mayo Clin. Proc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1634\/theoncologist.2009-0067","article-title":"Cancer awareness in atypical thrombotic microangiopathies","volume":"14","author":"Oberic","year":"2009","journal-title":"Oncologist"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.5045\/br.2018.53.2.167","article-title":"Microangiopathic hemolytic anemia as initial presentation of recurrent colon cancer","volume":"53","author":"Park","year":"2018","journal-title":"Blood Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s11805-008-0150-z","article-title":"Spontaneous tumor lysis syndrome and secondary thrombotic thrombocytopenic purpura in early stage colorectal cancer","volume":"5","author":"Usmani","year":"2008","journal-title":"Chin. J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.2217\/fon.14.113","article-title":"Metastatic cancer-related thrombotic microangiopathies: A cohort study","volume":"10","author":"Ducos","year":"2014","journal-title":"Future Oncol."},{"key":"ref_13","first-page":"198","article-title":"Thrombotic thrombocytopenic purpura following hemicolectomy for colonic carcinoma","volume":"12","author":"Robson","year":"1997","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc.-Eur. Ren. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.7326\/0003-4819-79-3-368","article-title":"Microangiopathic hemolytic anemia in metastatic carcinoma: Report of eight cases","volume":"79","author":"Lohrmann","year":"1973","journal-title":"Ann. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2141.1970.tb01433.x","article-title":"Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma","volume":"18","author":"Brain","year":"1970","journal-title":"Br. J. Haematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ajh.20783","article-title":"Management of cancer-associated thrombotic microangiopathy: What is the right approach?","volume":"82","author":"Werner","year":"2007","journal-title":"Am. J. Hematol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000421-200002000-00021","article-title":"Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast","volume":"23","author":"Sandherr","year":"2000","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_18","first-page":"284","article-title":"Metastatic colorectal cancer presenting with bone marrow metastasis: A case series and review of literature","volume":"7","author":"Assi","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1182\/blood-2014-11-551580","article-title":"How I treat refractory thrombotic thrombocytopenic purpura","volume":"125","author":"Sayani","year":"2015","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0609.2010.01448.x","article-title":"Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: An important diagnostic consideration","volume":"85","author":"Elliott","year":"2010","journal-title":"Eur. J. Haematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1634\/theoncologist.12-1-11","article-title":"Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases","volume":"12","author":"Francis","year":"2007","journal-title":"Oncologist"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1537-2995.2006.00687.x","article-title":"Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome","volume":"46","author":"Howard","year":"2006","journal-title":"Transfusion"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Babu, K.G., and Bhat, G.R. (2016). Cancer-associated thrombotic microangiopathy. Ecancermedicalscience, 10.","DOI":"10.3332\/ecancer.2016.649"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/ejh.12222","article-title":"Pulmonary involvement in patients with thrombotic thrombocytopenic purpura","volume":"92","author":"Nokes","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1200\/PO.19.00400","article-title":"Undetectable RAS-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With RAS-Mutant Metastatic Colorectal Cancer","volume":"4","author":"Bouchahda","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"ref_26","first-page":"192","article-title":"Palliative radiotherapy for advanced malignancies in a changing oncologic landscape: Guiding principles and practice implementation","volume":"3","author":"Jones","year":"2014","journal-title":"Ann. Palliat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1537-2995.2008.02082.x","article-title":"Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura","volume":"49","author":"Swisher","year":"2009","journal-title":"Transfusion"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3889\/oamjms.2018.163","article-title":"Pain relief as an integral part of the palliative care","volume":"6","author":"Sholjakova","year":"2018","journal-title":"Open Access Maced. J. Med. Sci."}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/15\/1\/2\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:58:36Z","timestamp":1760119116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/15\/1\/2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["hematolrep15010002"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep15010002","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]}}}